Barchart on MSN
What to expect from Amgen's next quarterly earnings report
With a market cap of $191.8 billion, Amgen Inc. (AMGN) is a global biotechnology company that discovers, develops, ...
Amgen Inc. (NASDAQ:AMGN) is included among the 10 Healthcare Stocks with Highest Dividends. On April 13, UBS lifted its price ...
(Bloomberg) -- Amgen Inc.’s drug Tavneos, used to treat a severe form of blood vessel inflammation, has been tied to serious liver injuries and eight deaths, the US Food and Drug Administration said.
Amgen Inc. (NASDAQ:AMGN) is included among the 13 NASDAQ Stocks with Highest Dividends. On April 10, Morgan Stanley analyst ...
Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on ...
Key timeline points show the study was first submitted on March 28, 2025, signaling the formal launch of the program. The record was last updated on March 31, 2026, which is relevant for investors ...
Amgen Inc. (NASDAQ:AMGN) is one of the best pharma stocks to invest in now. Amgen Inc. (NASDAQ:AMGN) announced on March 28 that Repatha® lowered the risk of first major adverse cardiovascular events ...
Amgen (AMGN) stock climbs as MariTide GLP-1 trials demonstrate nearly 20% weight loss. Truist raises price target to $325 ...
Amgen Inc. (AMGN) has reported a key update on its Phase 3 ROCKET-Outpost study, which looks at self-administered rocatinlimab in teens and adults with moderate-to-severe atopic dermatitis. The trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results